Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormone replacement therapy vs risedronate after hip fracture surgery in postmenopausal Korean women
KCT0005513Phase 4Active, not recruiting
- Sponsor
- Samsung Medical Center
- Start
- Apr 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of estradiol valerate + dydrogesterone, risedronate in hip fracture, osteoporosis, sponsored by Samsung Medical Center. Started Apr 2005; status: active, not recruiting.
02
Drugs
estradiol valerate + dydrogesteronerisedronate
03
Conditions
hip fractureosteoporosis
Beyond the preview
Go deeper on KCT0005513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005513.